BioSpace News Archive

Top Shelf Botanicals, The Beneficial Alternative, announced today it is continuing to expand in Montana with the grand opening of their Cannabis Dispensary in Helena

GetInsured, a leading provider of health insurance marketplace technology, retired $580,899 of medical debt in the state of Nevada after its first-ever Nevada Resident Medical Debt Survey revealed more than half (55 percent) of respondents did not seek and/or declined medical treatment out of fear of what it might cost.

Dovetail Genomics, the industry leader in advanced genomic solutions for proximity ligation, today announced the global availability of its latest Hi-C offering, Omni-C.

Mallinckrodt plc announced publication of results of its Phase 1b clinical trial of StrataGraft®, an investigational regenerative tissue, in Burns, the journal of the International Society for Burn Injuries.

Hagens Berman Sobol Shapiro LLP alerts investors in Evolent Health, Inc. to the securities class action, Plymouth County Retirement System v. Evolent Health, Inc. et al., No. 1:19-cv-01031 pending in the U.S. District Court for the Eastern District of Virginia.

Transaction Creates Expanded Portfolio of Cloud-Based Capabilities to Advance Clinical Development

Harvest One Inc. (“Harvest One” or the “Company”) (TSXV: HVT; OTCQX: HRVOF), through its wholly-owned subsidiary Satipharm Ltd. (“Satipharm”), today announced positive results of a Phase 2 clinical trial of its CBD GelPell® capsules in the management of Treatment Resistant Epilepsy

Utilizing more than a decade of expertise in security and technology for healthcare clients, Intraprise Health has created BluePrint Protect™ Security Risk Management Software

KIYATEC, Inc. today announced that Capital Health has joined its U.S. clinical trial, 3D-PREDICT, to validate the company’s test as a patient-specific predictor of response to cancer therapies in glioblastoma (GBM) and anaplastic astrocytoma (AA) patients.

Patients, families, and caregivers are invited to learn about gastric cancer and other cancer-related issues from oncology experts